Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (131-140 of 279) with videos related to

Pageof 28
Sort By:
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Geriatrics (Basel, Switzerland)|May 29, 2018
Using the A/T/N Framework to Examine Driving in Preclinical ADCatherine M Roe, Ganesh M Babulal, Sarah H Stout, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurobiology of Aging|March 25, 2021
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25Omar H Butt, Justin M Long, Rachel L Henson, et al.
Science Translational Medicine|January 11, 2019
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's diseaseBrendan P Lucey, Austin McCullough, Eric C Landsness, et al.
Archives of Neurology|December 17, 2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case reportNigel J Cairns, Milos D Ikonomovic, Tammie Benzinger, et al.
Neurology|September 11, 2020
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trialYvette I Sheline, B Joy Snider, Joanne C Beer, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Depression and Alzheimer's Disease Biomarkers Predict Driving DeclineGanesh M Babulal, Suzie Chen, Monique M Williams, et al.
Pageof 28

Showing results (131-140 of 279) with videos related to

Sort By:
Pageof 28
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Geriatrics (Basel, Switzerland)|May 29, 2018
Using the A/T/N Framework to Examine Driving in Preclinical ADCatherine M Roe, Ganesh M Babulal, Sarah H Stout, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurobiology of Aging|March 25, 2021
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25Omar H Butt, Justin M Long, Rachel L Henson, et al.
Science Translational Medicine|January 11, 2019
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's diseaseBrendan P Lucey, Austin McCullough, Eric C Landsness, et al.
Archives of Neurology|December 17, 2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case reportNigel J Cairns, Milos D Ikonomovic, Tammie Benzinger, et al.
Neurology|September 11, 2020
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trialYvette I Sheline, B Joy Snider, Joanne C Beer, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Depression and Alzheimer's Disease Biomarkers Predict Driving DeclineGanesh M Babulal, Suzie Chen, Monique M Williams, et al.
Pageof 28